J Mycol Infect.
2022 Mar;27(1):19-20. 10.17966/JMI.2022.27.1.19.
Pilomatricoma Developed After SARS-CoV-2 mRNA Vaccine Inoculation
- Affiliations
-
- 1Department of Dermatology, National Medical Center, Seoul, Korea
- KMID: 2536738
- DOI: http://doi.org/10.17966/JMI.2022.27.1.19
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Changes in SARS-CoV-2 antibody titers 6 months after the booster dose of BNT162b2 COVID-19 vaccine among health care workers
- SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
- New-Onset Fulminant Type 1 Diabetes Following SARS-CoV-2 Protein Subunit Vaccine: A Case Report and Literature Review
- Epidemiology, Virology, and Clinical Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2; Coronavirus Disease-19)
- Low Neutralizing Activities to the Omicron Subvariants BN.1 and XBB.1.5 of Sera From the Individuals Vaccinated With a BA.4/5-Containing Bivalent mRNA Vaccine
